Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery
Condition: Heart Valve Diseases Interventions: Drug: Six percent hydroxy ethyl starch 130/0.4; Drug: Ringer lactate Sponsors: Rajaie Cardiovascular Medical and Research Center; Heart Valve Disease Research Center Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials